Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. reported a net loss for the year ended December 31, 2023, of $556.5 million, a significant decrease from the net income of $902.6 million in 2022. The loss was primarily due to a $600 million gain on sale of real estate from the Macquarie Transaction in 2022, a $700 million impairment charge in 2023 related to Steward Health Care System, and accelerating the amortization of lease intangibles associated with the Steward Utah Transaction. Normalized FFO decreased by 13% to $951 million in 2023. The company also engaged in various strategic property sales, including the sale of 11 Australian properties for A$1.2 billion, and reduced its dividend from $0.29 to $0.15 per share in Q3 2023. Additionally, Medical Properties Trust faced legal proceedings, including a securities class action lawsuit and a defamation lawsuit against short-seller Viceroy Research LLC. The company's management concluded that internal control over financial reporting was effective as of December 31, 2023.

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. reported a net loss for the year ended December 31, 2023, of $556.5 million, a significant decrease from the net income of $902.6 million in 2022. The loss was primarily due to a $600 million gain on sale of real estate from the Macquarie Transaction in 2022, a $700 million impairment charge in 2023 related to Steward Health Care System, and accelerating the amortization of lease intangibles associated with the Steward Utah Transaction. Normalized FFO decreased by 13% to $951 million in 2023. The company also engaged in various strategic property sales, including the sale of 11 Australian properties for A$1.2 billion, and reduced its dividend from $0.29 to $0.15 per share in Q3 2023. Additionally, Medical Properties Trust faced legal proceedings, including a securities class action lawsuit and a defamation lawsuit against short-seller Viceroy Research LLC. The company's management concluded that internal control over financial reporting was effective as of December 31, 2023.